Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc (0HD2)

Market Closed
17 Jul, 15:30
LSE LSE
$
269. 85
-13.21
-4.6669%
$
- Market Cap
- P/E Ratio
- Div Yield
233 Volume
-3.56 Eps
$ 283.06
Previous Close
Add Transaction
Day Range
269.85 284.11
Year Range
269.85 500.21
Want to track 0HD2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Alnylam Pharmaceuticals Inc logo
0HD2 Alnylam Pharmaceuticals Inc
29 Apr 2026
-
-
Alnylam Pharmaceuticals Inc logo
0HD2 Alnylam Pharmaceuticals Inc
12 Feb 2026
1.5
1.37
Alnylam Pharmaceuticals Inc logo
0HD2 Alnylam Pharmaceuticals Inc
12 Jan 2026
-
-
Alnylam Pharmaceuticals Inc logo
0HD2 Alnylam Pharmaceuticals Inc
29 Oct 2025
-
-
Alnylam Pharmaceuticals Inc logo
0HD2 Alnylam Pharmaceuticals Inc
30 Jul 2025
-
-

0HD2 Earnings Reports FAQ

What is the earnings per share (EPS) for 0HD2?

The current EPS is -3.56.

What is the company's earnings growth rate?

Alnylam Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Alnylam Pharmaceuticals Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Alnylam Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0HD2 at this time, as Alnylam Pharmaceuticals Inc has no recent EPS data to calculate it.